1604610

Risedronate sodium

United States Pharmacopeia (USP) Reference Standard

• Sinónimos: Risedronic acid monosodium salt hemi(pentahydrate)
• Fórmula empírica (notación de Hill): C₇H₁₀NNaO₇P₂ · 2.5H₂O
• Número de CAS: 329003-65-8
• Peso molecular: 350.13
• Número MDL: MFCD01706268
• Código UNSPSC: 41116107
• NACRES: NA.24

Propiedades

• grado: pharmaceutical primary standard
• familia API: risedronate
• fabricante / nombre comercial: USP
• aplicaciones: pharmaceutical (small molecule)
• Formato: neat
• cadena SMILES: OP(C(P(O)([O-])=O)(O)CC1=CC=CN=C1)(O)=O.[Na+]
• InChI: 1S/2C7H11NO7P2.2Na.5H2O/c2*9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6;;;;;;;/h2*1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15);;;5*1H2/q;;2*+1;;;;;/p-2
• Clave InChI: HYFDYHPNTXOPPO-UHFFFAOYSA-L

Descripción

Descripción general

Risedronate sodium is a member of the pyridinyl class of bisphosphonates. It is mostly used as an antiresorptive agent. It can be used in treating and preventing postmenopausal and glucocorticoid-induced osteoporosis.

Aplicación

Risedronate sodium USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Risedronate Sodium Tablets
• Risedronate Sodium Delayed-Release Tablets

Nota de análisis

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Otras notas

Sales restrictions may apply.

Información de seguridad

• Pictogramas: GHS08,GHS07
• Palabra de señalización: Warning
• Frases de peligro: H302,H319,H361,H371
• Consejos de prudencia: P202 - P260 - P264 - P301 + P312 - P305 + P351 + P338 - P308 + P311
• Clasificaciones de peligro: Acute Tox. 4 Oral - Eye Irrit. 2 - Repr. 2 - STOT SE 2
• Código de clase de almacenamiento: 11 - Combustible Solids
• Clase de riesgo para el agua (WGK): WGK 3
• Punto de inflamabilidad (°F): Not applicable
• Punto de inflamabilidad (°C): Not applicable